{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:37:39Z","timestamp":1786981059990,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Project Coordination Unit of \u0130zmir Democracy University. Project number:TPF-20H04.","award":["TPF-20H04"],"award-info":[{"award-number":["TPF-20H04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10792-021-02109-0","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T01:02:47Z","timestamp":1635642167000},"page":"1233-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The evaluation of patient demographics, etiologies and apraclonidine test results in adult Horner's syndrome"],"prefix":"10.1007","volume":"42","author":[{"given":"Dilek","family":"Top Karti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5085-0079","authenticated-orcid":false,"given":"Omer","family":"Karti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsum","family":"Saruhan Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Gokcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Celebisoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,31]]},"reference":[{"key":"2109_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/acschemneuro.7b00405","volume":"9","author":"TJ Martin","year":"2018","unstructured":"Martin TJ (2018) Horner syndrome: a clinical review. ACS Chem Neurosci 9:177\u2013186","journal-title":"ACS Chem Neurosci"},{"key":"2109_CR2","first-page":"35","volume":"7","author":"S Kanagalingam","year":"2015","unstructured":"Kanagalingam S, Miller NR (2015) Horner syndrome: clinical perspectives. Eye Brain 7:35\u201346","journal-title":"Brain"},{"key":"2109_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2019.00055","volume":"10","author":"F Bremner","year":"2019","unstructured":"Bremner F (2019) Apraclonidine is better than cocaine for detection of Horner syndrome. Front Neurol 10:55","journal-title":"Front Neurol"},{"key":"2109_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10072-019-03773-y","volume":"40","author":"DT Karti","year":"2019","unstructured":"Karti DT, Karti O, Celebisoy N (2019) A rare cause of Horner\u2019s syndrome: cervicothoracic spinal root cysts. Neurol Sci 40:1311\u20131314","journal-title":"Neurol Sci"},{"key":"2109_CR5","unstructured":"Khan Z, Bollu PC. Horner Syndrome. 2021 May 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan\u2013. PMID: 29763176."},{"key":"2109_CR6","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s00415-020-10270-2","volume":"268","author":"J Han","year":"2021","unstructured":"Han J, Park SY, Lee JY (2021) Nationwide population-based incidence and etiologies of pediatric and adult Horner syndrome. J Neurol 268:1276\u20131283","journal-title":"J Neurol"},{"issue":"1","key":"2109_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNO.0b013e3181ce8145","volume":"30","author":"JD Trobe","year":"2010","unstructured":"Trobe JD (2010) The evaluation of Horner syndrome. J Neuroophthalmol 30(1):1\u20132","journal-title":"J Neuroophthalmol"},{"key":"2109_CR8","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.wneu.2019.08.190","volume":"133","author":"OA Gamaleldin","year":"2020","unstructured":"Gamaleldin OA, Donia MM, Elsebaie NA, Abdelkhalek Abdelrazek A, Rayan T, Khalifa MH (2020) Role of fused three-dimensional time-of-flight magnetic resonance angiography and 3-dimensional t2-weighted imaging sequences in neurovascular compression. World Neurosurg 133:e180\u2013e186","journal-title":"World Neurosurg"},{"key":"2109_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clinimag.2020.10.055","volume":"71","author":"AAKA Razek","year":"2021","unstructured":"Razek AAKA, Maher H, Kasem MA, Helmy E (2021) Imaging of congenital cranial dysinnervation disorders: what radiologist wants to know? Clin Imaging 71:106\u2013116","journal-title":"Clin Imaging"},{"key":"2109_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/RCT.0000000000001109","volume":"44","author":"AAK Abdel Razek","year":"2020","unstructured":"Abdel Razek AAK, Gamaleldin OA, Elsebaie NA (2020) Peripheral nerve sheath tumors of head and neck: imaging-based review of world health organization classification. J Comput Assist Tomogr 44:928\u2013940","journal-title":"J Comput Assist Tomogr"},{"key":"2109_CR11","first-page":"96","volume":"1","author":"H Wilhelm","year":"1992","unstructured":"Wilhelm H, Ochsner H, Kopycziok E, Trauzettel-Klosinski S, Schiefer U, Zrenner E (1992) Horner\u2019s syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol 1:96\u2013102","journal-title":"Ger J Ophthalmol"},{"key":"2109_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/WNO.0000000000000844","volume":"40","author":"MA Sabbagh","year":"2020","unstructured":"Sabbagh MA, De Lott LB, Trobe JD (2020) Causes of Horner syndrome: a study of 318 patients. J Neuroophthalmol 40:362\u2013369","journal-title":"J Neuroophthalmol"},{"key":"2109_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0002-9394(14)74924-4","volume":"90","author":"WF Maloney","year":"1980","unstructured":"Maloney WF, Younge BR, Moyer NJ (1980) Evaluation of the causes and accuracy of pharmacologic localization in Horner\u2019s syndrome. Am J Ophthalmol 90:394\u2013402","journal-title":"Am J Ophthalmol"},{"key":"2109_CR14","unstructured":"Thompson H, Maxner C, Corbett J. Horner\u2019s syndrome due to damage to the preganglionic neuron of the oculosympathetic pathway. In: Huber A, editor. Symphathetics and the Eye [English Translation]. Stuttgart, Germany: Ferdinand Enke; 1990"},{"key":"2109_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/01658107.2019.1625931","volume":"44","author":"D Top Karti","year":"2019","unstructured":"Top Karti D, Karti O, Koc AM, Esen O, Celebisoy N (2019) Unilateral Abducens nerve palsy with ipsilateral Horner\u2019s syndrome as an initial manifestation of recurrent nasopharyngeal carcinoma. Neuroophthalmology 44:379\u2013383","journal-title":"Neuroophthalmology"},{"key":"2109_CR16","first-page":"951","volume":"118","author":"J Morales","year":"2000","unstructured":"Morales J, Brown SM, Abdul-Rahim AS, Crosson CE (2000) Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 118:951\u2013954","journal-title":"Arch Ophthalmol"},{"key":"2109_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1444-0938.2007.00177.x","volume":"90","author":"YX Kong","year":"2007","unstructured":"Kong YX, Wright G, Pesudovs K, O\u2019Day J, Wainer Z, Weisinger HS (2007) Horner syndrome. Clin Exp Optom 90:336\u2013344","journal-title":"Clin Exp Optom"},{"key":"2109_CR18","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","volume":"89","author":"F Koc","year":"2005","unstructured":"Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E (2005) The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol 89:1442\u20131444","journal-title":"Br J Ophthalmol"},{"key":"2109_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jaapos.2007.02.015","volume":"11","author":"P Watts","year":"2007","unstructured":"Watts P, Satterfuekd D, Lim MK (2007) Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. J AAPOS 11:282\u2013283","journal-title":"J AAPOS"},{"key":"2109_CR20","first-page":"281","volume":"5","author":"LB Enyedi","year":"2001","unstructured":"Enyedi LB, Freedman SF (2001) Safety and efficacy of brimonidine in children with glaucoma. J JAAPOS 5:281\u2013284","journal-title":"J JAAPOS"},{"key":"2109_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9394(99)00083-5","volume":"128","author":"J Carlson","year":"1999","unstructured":"Carlson J, Zabriskie N, Known T, Barbe ME, Scott WE (1999) Apparent central nervous system depression in infants after the use of topical brimonidine. Am J Ophthalmol 128:255\u2013256","journal-title":"Am J Ophthalmol"},{"key":"2109_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/jop.2006.22.182","volume":"22","author":"PL Chen","year":"2006","unstructured":"Chen PL, Chen JT, Lu DW, Chen YC, Hsiao CH (2006) Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients. J Ocul Pharmacol Ther 22:182\u2013187","journal-title":"J Ocul Pharmacol Ther"},{"key":"2109_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajo.2006.05.047","volume":"142","author":"NR Mahoney","year":"2006","unstructured":"Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM (2006) Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol 142:651\u2013659","journal-title":"Am J Ophthalmol"},{"key":"2109_CR24","first-page":"69","volume":"25","author":"R Kardon","year":"2005","unstructured":"Kardon R (2005) Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome? J Neuroophthalmol 25:69\u201370","journal-title":"J Neuroophthalmol"},{"key":"2109_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/WNO.0b013e318175d206","volume":"28","author":"BL Bohnsack","year":"2008","unstructured":"Bohnsack BL, Parker JW (2008) Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection. J Neuroophthalmol 28:235\u2013236","journal-title":"J Neuroophthalmol"},{"issue":"276\u20139","key":"2109_CR26","first-page":"5","volume":"122","author":"D Bacal","year":"2004","unstructured":"Bacal D, Levy SR (2004) The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 122(276\u20139):5","journal-title":"Arch Ophthalmol"},{"key":"2109_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/archopht.121.8.1201","volume":"121","author":"SM Brown","year":"2003","unstructured":"Brown SM, Aouchiche R, Freedman KA (2003) The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 121:1201\u20131203","journal-title":"Arch Ophthalmol"},{"key":"2109_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ajo.2006.04.052","volume":"142","author":"PL Chen","year":"2006","unstructured":"Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY (2006) Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. Am J Ophthalmol 142:469\u2013474","journal-title":"Am J Ophthalmol"},{"key":"2109_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/014556130708600508","volume":"86","author":"EA Chu","year":"2007","unstructured":"Chu EA, Byrne PJ (2007) Pharmacologic reversal of Horner\u2019s syndrome related ptosis with apraclonidine. Ear Nose Throat J 86:270\u2013273","journal-title":"Ear Nose Throat J"},{"key":"2109_CR30","first-page":"83","volume":"25","author":"KA Freedman","year":"2005","unstructured":"Freedman KA, Brown SM (2005) Topical apraclonidine in the diagnosis of suspected Horner syndrome. J Neuroophthalmol 25:83\u201385","journal-title":"J Neuroophthalmol"},{"key":"2109_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/01.iop.0000196322.05586.6a","volume":"22","author":"DC Garibaldi","year":"2006","unstructured":"Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL (2006) Effect of 0.5% apraclonidine on ptosis in Horner syndrome. Ophthalmic Plast Reconstr Surg 22:53\u201355","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02109-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:19:32Z","timestamp":1649384372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02109-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"assertion":[{"value":"19 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the tenets of the Helsinki Declaration after obtaining the approval of local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"There was no research on animals in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal research"}}]}}